Evidence map›Paper›PMID 28573510›Full record

ArticleVirchows Archiv : an international journal of pathology2017

B-cell lymphomas with discordance between pathological features and clinical behavior.

Laurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, Lisa Rimsza, Stefania Pittaluga, Bettina Bisig, Stefan Dirnhofer, Fabio Facchetti, Stefano Pileri, Falko Fend and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 6 countries.

Laurence de LevalInstitute of Pathology, University Hospital Lausanne (CHUV), 25 Rue du Bugnon, CH-1011, Lausanne, Switzerland. Laurence.deLeval@chuv.ch.
Christiane Copie-BergmanDepartment of Pathology, Hopital Henri Mondor, INSERM U955, Université Paris Est, Creteil, France.
Andreas RosenwaldInstitute of Pathology, University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
Lisa RimszaDepartment of Laboratory Medicine and Pathology, the Mayo Clinic, Scottsdale, AZ, USA.
Stefania PittalugaLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Bettina BisigInstitute of Pathology, University Hospital Lausanne (CHUV), 25 Rue du Bugnon, CH-1011, Lausanne, Switzerland.
Stefan DirnhoferInstitute of Pathology and Genetics, University Hospital Basel, Basel, Switzerland.
Fabio FacchettiSection of Pathology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Stefano PileriUnit of Hematopathology, European Institute of Oncology, Milan, Italy.
Falko FendInstitute of Pathology and Neuropathology and Comprehensive Cancer Center, University Hospital Tübingen, Tubingen, Germany.
Andrew WotherspoonDepartment of Pathology, Royal Marsden Hospital, London, Sutton, UK.
University Hospital of Lausanne · CHCenter for Cancer Research · USComprehensive Cancer Center Mainfranken · DEEuropean Institute of Oncology · ITRoyal Marsden Hospital · GBUniversité Paris-Est Créteil · FRUniversity Children's Hospital Tübingen · DEUniversity Hospital of Basel · CHUniversity of Brescia · ITWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell lymphomas encompass a large number of disease entities clinically ranging from indolent to aggressive. The defining pathological features usually predict clinical course, with small and large B-cell lymphomas correlating to low-grade vs high-grade features, but discordant situations may be encountered. Two sessions of the workshop of the XVIII meeting of the European Association for Haematopathology (EAHP) held in Basel in 2016 addressed this topic. One session illustrated various facets of "aggressiveness" in indolent lymphomas, either peculiar clinical manifestations, cytological variants, or unusual genetic features, as well as several examples of progression or transformation to a more aggressive disease. Another session exemplified large B-cell lymphomas with unexpected indolent behavior including cases arising in well-defined body compartments or in sanctuary sites. This paper describes the features of the cases presented in both groups, highlights the most salient points of discussion raised by the submitters and the panel, and summarizes current knowledge and recommendations relevant to diagnostic pathology practice.

Indexed as

Disease ProgressionFemaleHumansLymphoma, Non-HodgkinMaleB-cell lymphomasClinical behaviorCytologyDiscordanceGeneticsPathological featuresProgressionTransformation

Identifiers

PMID28573510
OpenAlexW2621087076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.